Previous studies reported that dyslipidemia was closely related to the progression of pancreatic ductal adenocarcinoma (PDAC) [26], the epithelial-to-mesenchymal transition (EMT) of prostate cancer [27] and the recurrence of early-stage, hormone receptor-positive invasive breast cancer [28]. Here, NR4A1 is linked to prostate carcinoma.